ALISA PICOU: Open Payments
NPI 1346705100 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 60 payments from 13 companies in 2025. Trend: 2023 $1,424 · 2024 $647 · 2025 $1,156
Food & beverage: $1,156
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 6 | $328 |
| ABBVIE INC. | 25 | $307 |
| Regeneron Healthcare Solutions, Inc. | 4 | $125 |
| Janssen Biotech, Inc. | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 7 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Ardelyx, Inc. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| QOL Medical, LLC | 2 | $32 |
| Intercept Pharmaceuticals, Inc. | 2 | $29 |
Products named: VEGZELMA, RINVOQ, DUPIXENT, TREMFYA, VOQUEZNA, VIBERZI, ENTYVIO, IBSRELA.
Industry payments across LA — which companies pay providers there.
